Literature DB >> 9865673

Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes.

J A Staessen1, G Ginocchio, J G Wang, A P Saavedra, F Soubrier, R Vlietinck, R Fagard.   

Abstract

BACKGROUND: Variants of the human genes coding for renin, angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and the angiotensin II type-I receptor (AT1R) are inconsistently associated with cardiovascular-renal disease, possibly because of genetic differences in the background populations.
METHODS: This systematic review of the literature investigated genetic variation in the renin system according to race, sex and age. Across studies with relevant information, multivariate analyses also accounted for the methods of genotyping and the enrollment of subjects as controls, cases or groups studied cross-sectionally.
RESULTS: The 185 reviewed reports included 64978 subjects. In five studies (n=989) on the renin gene, the Hind III and Taq I polymorphisms varied with the groups' average age, whereas the Bg I, Bg II and Hind III but not Taq I sites differed according to race. Among 135 studies (n=44697) on the deletion/insertion (D/I) polymorphism of the ACE gene, the frequency of the D allele was 54.0%. Its prevalence was not related to sex and black race, was 49.9% lower in Asians, 10.0% lower in studies relying on I-specific primers, 4.9% higher for each 25-year increment in the average age of the groups studied, and 16.7% higher in cases than controls. Among 12 studies (n=4952) on the T174-->M variant of the AGT gene, the M174 frequency was 11.0%, did not vary according to sex and enrollment group, was 56.7% lower in blacks and 39.5% lower for each 25-year increase in the groups' mean age. Across 44 studies (n=16713) on the M235-->T substitution in the AGT gene, the T235 prevalence was 51.6%. Its frequency was not related to sex and the method of genotyping, tended to be 7.5% lower for each 25-year increase in average age, was from 4.6 to 6.6 times higher in nonwhites than whites and 13.2% higher in cases than controls. Among 13 studies (n=4332) on the A1166-->C variant of the AT1R gene, the C1166 allelic frequency was 25.7%. Its prevalence was independent of the enrollment group, 77.4% lower in Asians, and nearly doubled for each 25-year increment in age.
CONCLUSION: With adjustments applied for the subjects' enrollment group and the methods of genotyping, genetic polymorphism in the renin system varies according to race and age, but not sex. One possible application of the present results is to provide allelic and genotypic frequencies, which could be used to assess power, to perform sample size calculations, or to predict selection bias in future studies.

Entities:  

Mesh:

Year:  1997        PMID: 9865673

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  17 in total

1.  Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension.

Authors:  Egidio Imbalzano; Marco Vatrano; Sebastiano Quartuccio; Rossella Di Stefano; Caterina Oriana Aragona; Federica Mamone; Angela D'Ascola; Michele Scuruchi; Francesca Felice; Giovanni Trapani; Angela Alibrandi; Vincenzo Antonio Ciconte; Roberto Ceravolo; Antonino Saitta; Giuseppe Mandraffino
Journal:  Mol Cell Biochem       Date:  2017-02-11       Impact factor: 3.396

2.  The Alu polymorphism of angiotensin I converting enzyme (ACE) and atherosclerosis, incident chronic diseases and mortality in an elderly Chinese population.

Authors:  J Woo; N L S Tang; J Leung; T Kwok
Journal:  J Nutr Health Aging       Date:  2012-03       Impact factor: 4.075

3.  Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Authors:  Paul R Gard
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-20

Review 4.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury.

Authors:  N J Mayer; A Forsyth; S Kantachuvesiri; J J Mullins; S Fleming
Journal:  Mol Pathol       Date:  2002-02

6.  Patterned variation in murine MHC promoters.

Authors:  N Avrion Mitchison; Jurgen Roes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

7.  Variants in blood pressure genes and the risk of renal cell carcinoma.

Authors:  Gabriella Andreotti; Paolo Boffetta; Philip S Rosenberg; Sonja I Berndt; Sara Karami; Idan Menashe; Meredith Yeager; Stephen J Chanock; David Zaridze; Vsevolod Matteev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Nathaniel Rothman; Paul Brennan; Wong-Ho Chow; Lee E Moore
Journal:  Carcinogenesis       Date:  2010-01-04       Impact factor: 4.944

8.  Epidemiology of essential hypertension: the role of genetic polymorphism.

Authors:  V Romano-Spica; M Mettimano; A Ianni; M L Specchia; G Ricciardi; L Savi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

9.  Angiotensin-converting enzyme i/d polymorphism in patients with malignant hypertension.

Authors:  Eugenia Espinel; Jose Luis Tovar; Javier Borrellas; Luis Piera; Rosendo Jardi; Francisco Rodriguez Frias; Luis Armadans; Ana Gonzalez Bachs
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-01       Impact factor: 3.738

10.  Evaluation of Angiotensinogen M235T and T174M Polymorphisms, Demographic and Clinical Factors in New-Onset Diabetes after Liver Transplantation in Iranian Patients.

Authors:  S Mottaghi; N Azarpira; A Dehshahri; B Khalvati; S Namazi
Journal:  Int J Organ Transplant Med       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.